These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36505413)

  • 21. Epidermal growth factor receptor and ligand family expression and activity in glioblastoma.
    von Achenbach C; Weller M; Szabo E
    J Neurochem; 2018 Oct; 147(1):99-109. PubMed ID: 29953622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands.
    O-charoenrat P; Rhys-Evans P; Court WJ; Box GM; Eccles SA
    Clin Exp Metastasis; 1999; 17(7):631-9. PubMed ID: 10845563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of EGFR ligands on endocytic sorting of the receptor.
    Roepstorff K; Grandal MV; Henriksen L; Knudsen SL; Lerdrup M; Grøvdal L; Willumsen BM; van Deurs B
    Traffic; 2009 Aug; 10(8):1115-27. PubMed ID: 19531065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
    O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
    Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignant peripheral nerve sheath tumor invasion requires aberrantly expressed EGF receptors and is variably enhanced by multiple EGF family ligands.
    Byer SJ; Brossier NM; Peavler LT; Eckert JM; Watkins S; Roth KA; Carroll SL
    J Neuropathol Exp Neurol; 2013 Mar; 72(3):219-33. PubMed ID: 23399900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human betacellulin structure modeled from other members of EGF family.
    López-Torrejón I; Querol E; Avilés FX; Seno M; de Llorens R; Oliva B
    J Mol Model; 2002 Apr; 8(4):131-44. PubMed ID: 12111392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.
    Hinkle CL; Sunnarborg SW; Loiselle D; Parker CE; Stevenson M; Russell WE; Lee DC
    J Biol Chem; 2004 Jun; 279(23):24179-88. PubMed ID: 15066986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of EGF receptor ligands in TCDD-induced EGFR down-regulation and cellular proliferation.
    Campion CM; Leon Carrion S; Mamidanna G; Sutter CH; Sutter TR; Cole JA
    Chem Biol Interact; 2016 Jun; 253():38-47. PubMed ID: 27117977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selecting Nanobodies Specific for the Epidermal Growth Factor from a Synthetic Nanobody Library.
    Serrano-Rivero Y; Salazar-Uribe J; Rubio-Carrasquilla M; Camacho-Casanova F; Sánchez-Ramos O; González-Pose A; Moreno E
    Molecules; 2023 May; 28(10):. PubMed ID: 37241784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural insights into the non-inhibitory mechanism of the anti-EGFR EgB4 nanobody.
    Zeronian MR; Doulkeridou S; van Bergen En Henegouwen PMP; Janssen BJC
    BMC Mol Cell Biol; 2022 Mar; 23(1):12. PubMed ID: 35232398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of receptor protein binding site specificity and relative binding strength using a time-resolved competition assay.
    Barta P; Volkova M; Dascalu A; Spiegelberg D; Trejtnar F; Andersson K
    J Pharmacol Toxicol Methods; 2014; 70(2):145-51. PubMed ID: 25084055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of different ligands on epidermal growth factor receptor (EGFR) nuclear translocation.
    Faria JAQA; de Andrade C; Goes AM; Rodrigues MA; Gomes DA
    Biochem Biophys Res Commun; 2016 Sep; 478(1):39-45. PubMed ID: 27462018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor.
    Buteau J; Foisy S; Joly E; Prentki M
    Diabetes; 2003 Jan; 52(1):124-32. PubMed ID: 12502502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression.
    el-Marjou A; Delouvée A; Thiery JP; Radvanyi F
    Carcinogenesis; 2000 Dec; 21(12):2211-8. PubMed ID: 11133810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.
    Zhang X; Diaz MR; Yee D
    Breast Cancer Res Treat; 2013 Jun; 139(2):351-60. PubMed ID: 23686416
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.